What's driving the UK tax insurance boom?
Lower prices, deeper expertise and broader risk appetites are just some of the factors behind huge growth in the market.
Source: icaew.com
Specialty Head News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Specialty Head. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Specialty Head Today - Breaking & Trending Today
First European ustekinumab biosimilar to Stelara approved
The European Commission has granted a marketing authorisation for Uzpruvo® in Europe, a biosimilar candidate to Stelara® . Ustekinumab biologic ...
Source: marketscreener.com
STADA and Alvotech Secure Approval for Uzpruvo, Europe's First Ustekinumab Biosimilar to Stelara -January 10, 2024 at 03:31 am EST
Marketing authorization issued in European Economic Area for Uzpruvo®, the first biosimilar to Stelara®, a biologic therapy within gastroenterology, dermatology, and rheumatology Authorization paves...
Source: marketscreener.com
STADA and Alvotech Secure Approval for Uzpruvo, Europe's
Marketing authorization issued in European Economic Area for Uzpruvo®, the first biosimilar to Stelara®, a biologic therapy within gastroenterology,...
Source: globenewswire.com
STADA and Alvotech's win first EU-approval for Stelara biosimilar - Pharmaceutical Technology
STADA and Alvotech’s Uzpruvo gained an EU marketing authorisation, allowing it to be sold in the European Economic Area in 2024.
Source: pharmaceutical-technology.com